If you notice your dog is constantly scratching, licking, or chewing, it could be due to atopic dermatitis, a medical condition requiring professional treatment. Just like people, dogs can be allergic to common substances in the environment, such as grass and tree pollen, mold, and dust mites. Dogs may also be allergic to fleas, carpets, insecticides, and even ingredients in shampoos. These allergens can trigger itch and the cycle begins. It is important to make an appointment with your veterinarian to determine the cause of your dog’s environmental allergic itch and discuss appropriate treatment. Learn more.
CYTOPOINT is specifically designed to target your dog’s itch at the source. It is an injection that controls atopic dermatitis for 4-8 weeks.*1
CYTOPOINT is not like traditional pharmaceutical treatments for atopic dermatitis. This biological medication is a protein, not a drug, that works like your dog’s own immune system to block the signals that trigger environmental allergic itch.2,3
CYTOPOINT is available at your veterinarian’s office. It is an injection that is safely delivered right in the office for comfort, convenience and peace of mind.
CYTOPOINT works like your dog’s own immune system to relieve environmental allergic dog itch. It blocks the protein that sends signals that trigger itch, so the constant scratching can stop. In studies, after one injection, CYTOPOINT started controlling itch within 1 day and provided relief. CYTOPOINT has also been shown to help damaged skin begin to heal within 7 days.1 See the cycle of environmental allergic itch and how CYTOPOINT helps.
Some dogs have year-round disease and may need continuous treatment with CYTOPOINT, whereas other dogs may only need CYTOPOINT seasonally. You and your veterinarian should decide together what is best for your dog’s specific situation.
Just one CYTOPOINT injection starts controlling environmental allergic itch within one day and provides relief that lasts for 4 to 8 weeks.*1 That means your dog may be able to go as long as 8 weeks between injections.1
Your veterinarian may schedule a progress exam four weeks after the first injection. But, it’s dependent on your dog’s individual needs. So, please consult your veterinarian.
Every dog is different, so monitoring your dog’s itch is important. If you notice your dog is frequently scratching, licking or chewing, you should call your veterinarian. Your veterinarian may want to adjust your dog’s CYTOPOINT injection schedule.
You can keep track of your dog’s environmental allergic itch with the CYTOPOINT Environmental Itch Tracker. It’s simple to use and downloadable.
Yes! CYTOPOINT is safe to use in dogs of any age.
CYTOPOINT can also be used in dogs on many other medications or dogs with other diseases.4 As always, be sure to tell your veterinarian about all the medications your dog is taking.
A clinical study showed dogs receiving CYTOPOINT had no more side effects than dogs receiving placebo (injections without medication).4 Some of the most common side effects reported with both CYTOPOINT and placebo were dermatitis and bacterial skin infection.4 And since CYTOPOINT is not a drug-based treatment, it does not put pressure on the liver and kidneys.
As with any other treatment, it is good medical practice for the veterinarian to make an appropriate risk/benefit assessment for each individual patient when considering CYTOPOINT. Please contact your veterinarian if you would like to know more information or have questions about any potential adverse effects for CYTOPOINT.
There are several resources available for you to get more information on environmental allergic dog itch.
*Repeat administration every 4 to 8 weeks as needed in the individual patient.1
References: 1. Company Data – Study No. C863R-US-12-018, Zoetis Inc. 2. Gonzales AJ, Humphrey WR, Messamore JE, et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol. 2013;24(1):48-53. doi:10.1111/j.136S-3164.2012.01098.x. 3. Olivry T, Bäumer W. Atopic itch in dogs: pharmacology and modeling. In: Cowan A, Yosipovitch G, eds. Pharmacology of Itch, Handbook of Experimental Pharmacology. 2015:357-369. 4. Company Data – Study Report No. C961R-US-13-051, Zoetis Inc.
The product information provided in this site is intended only for residents of Canada. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.
Zoetis® and Cytopoint are registered trademarks of Zoetis or its licensors, used under license by Zoetis Canada Inc.
© 2020 Zoetis Services LLC. All rights reserved.